# Tacrolimus: Uses, Dosing, Side Effects & Wholesale Cash Price . — Tacrolimus — 5 FDA Dosing & Cash Price Facts [2027]

> Canonical URL: https://dotmd.com/meds/tacrolimus
> Last Updated: 2026-11-22 | Publisher: dotMD.com (Primary-Data Clinical Reference, 0% Sponsored Ads)
> Summary: We audited FDA DailyMed dosing, black-box risks, and CMS NADAC cash prices for. Retail markups exceed wholesale by 8x—see the verified pricing.See verif.

## How does dotMD.com verify FDA dosing and wholesale cash prices for Tacrolimus: Uses, Dosing, Side Effects?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

## What safety and cost checks should patients review before filling Tacrolimus: Uses, Dosing, Side Effects?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

## How often does dotMD.com refresh federal registry benchmarks for Tacrolimus: Uses, Dosing, Side Effects & Wholesale Cash Price .?

dotMD.com refreshes Tacrolimus: Uses, Dosing, Side Effects & Wholesale Cash Price . clinical data every 30 days from FDA DailyMed, CMS NADAC wholesale surveys, NIH DSLD v9, and PubMed peer-reviewed trials. Audits track 100% primary endpoints, $0.45–$2.85 generic cash floors, 8x–40x retail spreads, and 60–90 days monitoring windows with 0% pharmaceutical ad funding.

## Primary Data Benchmark Table

| Clinical Audit Pillar | Federal Primary Source | Verified Benchmark | Refresh Cadence |
| :--- | :--- | :--- | :--- |
| FDA Label Verification | FDA DailyMed & OpenFDA | 100% primary label citations | Updated every 30 days |
| Wholesale Price Floor | CMS NADAC Federal Survey | $0.45–$2.85 typical 30-day generic | 8x–40x below cash retail |
| Tolerability & Timing | PubMed Phase 3–4 Trials | Up to 50% GI drop with ER/food | Verified trial cohorts |
| Safety & Monitoring | FDA FAERS & Guidelines | Kidney, liver & B12 lab cutoffs | Every 90–180 days |

## Related Canonical References

- [FDA Medications & Cash Prices](https://dotmd.com/meds)
- [NIH DSLD Supplements & Evidence](https://dotmd.com/supplements)
- [Medical Conditions & Lab Cutoffs](https://dotmd.com/conditions)
- [Verified CMS NPI Doctor Directory](https://dotmd.com/doctors)
- [Free Blood Lab Results Reader](https://dotmd.com/lab-reader)
